Welcome to the InfoSci Platform
Big Data Approaches to Improve Stereotactic Body Radiation Therapy (SBRT) Outcomes: Big Data for SBRT

Big Data Approaches to Improve Stereotactic Body Radiation Therapy (SBRT) Outcomes: Big Data for SBRT

Issam El Naqa, Michael T. Milano, Nitin Ohri, Vitali Moiseenko, Eduardo G. Moros, Joseph O. Deasy, Jimm Grimm, Jinyu Xue, Mary Martel, Randall K. Ten Haken
Copyright: © 2018 |Pages: 20
ISBN13: 9781522530855|ISBN10: 1522530851|EISBN13: 9781522530862
DOI: 10.4018/978-1-5225-3085-5.ch004
Cite Chapter Cite Chapter

MLA

El Naqa, Issam, et al. "Big Data Approaches to Improve Stereotactic Body Radiation Therapy (SBRT) Outcomes: Big Data for SBRT." Emerging Developments and Practices in Oncology, edited by Issam El Naqa, IGI Global, 2018, pp. 94-113. https://doi.org/10.4018/978-1-5225-3085-5.ch004

APA

El Naqa, I., Milano, M. T., Ohri, N., Moiseenko, V., Moros, E. G., Deasy, J. O., Grimm, J., Xue, J., Martel, M., & Ten Haken, R. K. (2018). Big Data Approaches to Improve Stereotactic Body Radiation Therapy (SBRT) Outcomes: Big Data for SBRT. In I. El Naqa (Ed.), Emerging Developments and Practices in Oncology (pp. 94-113). IGI Global. https://doi.org/10.4018/978-1-5225-3085-5.ch004

Chicago

El Naqa, Issam, et al. "Big Data Approaches to Improve Stereotactic Body Radiation Therapy (SBRT) Outcomes: Big Data for SBRT." In Emerging Developments and Practices in Oncology, edited by Issam El Naqa, 94-113. Hershey, PA: IGI Global, 2018. https://doi.org/10.4018/978-1-5225-3085-5.ch004

Export Reference

Mendeley
Favorite

Abstract

‘Big data' approaches carry promise for advancing our understanding of stereotactic body radiation therapy (SBRT) (also termed stereotactic ablative radiotherapy, SABR) and is guiding the design of clinical trials using hypofractionated radiotherapy. However, the field of big data in radiotherapy, or in combination with other therapies, is still in its infancy and will likely benefit from multidisciplinary collaborative teams including physicians, physicists, radiobiologists, biostatisticians, bioinformaticists and other data scientists analyzing shared data. We herein review opportunities to use the Big data (including dosimetry, clinical factors, imaging and biomarkers/genomics) to improve SBRT outcomes.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.